Literature DB >> 10442233

Pharmacotherapy in children and adolescents with obsessive-compulsive disorder.

M Grados1, L Scahill, M A Riddle.   

Abstract

This article examines the general principles of psychopharmacologic treatment of obsessive-compulsive disorder (OCD) in children and adolescents. It includes a description of the currently approved medications for the treatment of children and adolescents with OCD, their side effect profiles, approaches to refractory OCD, and a discussion of drug interactions. Future directions for research are also considered.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10442233

Source DB:  PubMed          Journal:  Child Adolesc Psychiatr Clin N Am        ISSN： 1056-4993


  8 in total

1.  Age differences in the sensitivity to clomipramine in an animal model of obsessive-compulsive disorder.

Authors:  A Fernández-Guasti; R E Ulloa; H Nicolini
Journal:  Psychopharmacology (Berl)       Date:  2003-02-13       Impact factor: 4.530

Review 2.  Treatment approaches for children with Tourette's syndrome.

Authors:  Bennett L Lavenstein
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

Review 3.  Fluvoxamine: a review of its therapeutic potential in the management of anxiety disorders in children and adolescents.

Authors:  S M Cheer; D P Figgitt
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 4.  School refusal: epidemiology and management.

Authors:  D Heyne; N J King; B J Tonge; H Cooper
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 5.  Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited.

Authors:  Lara Menzies; Samuel R Chamberlain; Angela R Laird; Sarah M Thelen; Barbara J Sahakian; Ed T Bullmore
Journal:  Neurosci Biobehav Rev       Date:  2007-10-17       Impact factor: 8.989

Review 6.  Children with obsessive-compulsive disorder: are they just "little adults"?

Authors:  Simran K Kalra; Susan E Swedo
Journal:  J Clin Invest       Date:  2009-04-01       Impact factor: 14.808

7.  A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).

Authors:  Javad Alaghband-Rad; Mitra Hakimshooshtary
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-02-03       Impact factor: 4.785

8.  A neuropsychiatric review of pediatric obsessive-compulsive disorder: etiology and efficacious treatments.

Authors:  Adam B Lewin; Eric A Storch; Gary R Geffken; Wayne K Goodman; Tanya K Murphy
Journal:  Neuropsychiatr Dis Treat       Date:  2006-03       Impact factor: 2.570
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.